2000 to Present. Adult Tobacco Consumption in the U.S. This dataset highlights critical trends in adult total and per capita consumption of both combustible (cigarettes, little cigars, small cigars, pipe tobacco, roll-your-own tobacco) tobacco products and smokeless (chewing tobacco and snuff) tobacco from 2000 to present. To view the CDC MMWR report, please visit https://www.cdc.gov/mmwr/volumes/65/wr/mm6548a1.htm.

Graph and download economic data for Tobacco Consumption, Small Cigarettes for United States (M0187AUSM241NNBR) from Jan 1915 to Dec 1944 about tobacco, consumption, and USA.

This database contains tobacco consumption data from 1970-2015 collected through a systematic search coupled with consultation with country and subject-matter experts. Data quality appraisal was conducted by at least two research team members in duplicate, with greater weight given to official government sources. All data was standardized into units of cigarettes consumed and a detailed accounting of data quality and sourcing was prepared. Data was found for 82 of 214 countries for which searches for national cigarette consumption data were conducted, representing over 95% of global cigarette consumption and 85% of the world’s population. Cigarette consumption fell in most countries over the past three decades but trends in country specific consumption were highly variable. For example, China consumed 2.5 million metric tonnes (MMT) of cigarettes in 2013, more than Russia (0.36 MMT), the United States (0.28 MMT), Indonesia (0.28 MMT), Japan (0.20 MMT), and the next 35 highest consuming countries combined. The US and Japan achieved reductions of more than 0.1 MMT from a decade earlier, whereas Russian consumption plateaued, and Chinese and Indonesian consumption increased by 0.75 MMT and 0.1 MMT, respectively. These data generally concord with modelled country level data from the Institute for Health Metrics and Evaluation and have the additional advantage of not smoothing year-over-year discontinuities that are necessary for robust quasi-experimental impact evaluations. Before this study, publicly available data on cigarette consumption have been limited—either inappropriate for quasi-experimental impact evaluations (modelled data), held privately by companies (proprietary data), or widely dispersed across many national statistical agencies and research organisations (disaggregated data). This new dataset confirms that cigarette consumption has decreased in most countries over the past three decades, but that secular country specific consumption trends are highly variable. The findings underscore the need for more robust processes in data reporting, ideally built into international legal instruments or other mandated processes. To monitor the impact of the WHO Framework Convention on Tobacco Control and other tobacco control interventions, data on national tobacco production, trade, and sales should be routinely collected and openly reported. The first use of this database for a quasi-experimental impact evaluation of the WHO Framework Convention on Tobacco Control is: Hoffman SJ, Poirier MJP, Katwyk SRV, Baral P, Sritharan L. Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption: quasi-experimental evaluations using interrupted time series analysis and in-sample forecast event modelling. BMJ. 2019 Jun 19;365:l2287. doi: https://doi.org/10.1136/bmj.l2287 Another use of this database was to systematically code and classify longitudinal cigarette consumption trajectories in European countries since 1970 in: Poirier MJ, Lin G, Watson LK, Hoffman SJ. Classifying European cigarette consumption trajectories from 1970 to 2015. Tobacco Control. 2022 Jan. DOI: 10.1136/tobaccocontrol-2021-056627. Statement of Contributions: Conceived the study: GEG, SJH Identified multi-country datasets: GEG, MP Extracted data from multi-country datasets: MP Quality assessment of data: MP, GEG Selection of data for final analysis: MP, GEG Data cleaning and management: MP, GL Internet searches: MP (English, French, Spanish, Portuguese), GEG (English, French), MYS (Chinese), SKA (Persian), SFK (Arabic); AG, EG, BL, MM, YM, NN, EN, HR, KV, CW, and JW (English), GL (English) Identification of key informants: GEG, GP Project Management: LS, JM, MP, SJH, GEG Contacts with Statistical Agencies: MP, GEG, MYS, SKA, SFK, GP, BL, MM, YM, NN, HR, KV, JW, GL Contacts with key informants: GEG, MP, GP, MYS, GP Funding: GEG, SJH SJH: Hoffman, SJ; JM: Mammone J; SRVK: Rogers Van Katwyk, S; LS: Sritharan, L; MT: Tran, M; SAK: Al-Khateeb, S; AG: Grjibovski, A.; EG: Gunn, E; SKA: Kamali-Anaraki, S; BL: Li, B; MM: Mahendren, M; YM: Mansoor, Y; NN: Natt, N; EN: Nwokoro, E; HR: Randhawa, H; MYS: Yunju Song, M; KV: Vercammen, K; CW: Wang, C; JW: Woo, J; MJPP: Poirier, MJP; GEG: Guindon, EG; GP: Paraje, G; GL Gigi Lin Key informants who provided data: Corne van Walbeek (South Africa, Jamaica) Frank Chaloupka (US) Ayda Yurekli (Turkey) Dardo Curti (Uruguay) Bungon Ritthiphakdee (Thailand) Jakub Lobaszewski (Poland) Guillermo Paraje (Chile, Argentina) Key informants who provided useful insights: Carlos Manuel Guerrero López (Mexico) Muhammad Jami Husain (Bangladesh) Nigar Nargis (Bangladesh) Rijo M John (India) Evan Blecher (Nigeria, Indonesia, Philippines, South Africa) Yagya Karki (Nepal) Anne CK Quah (Malaysia) Nery Suarez Lugo (Cuba) Agencies providing assistance: Iranian Tobacco Co. Institut National de la Statistique (Tunisia) HM Revenue & Customs (UK) Eidgenössisches Finanzdepartement EFD/Département...

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of people who use or do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled Primary Sampling Unit (PSU)s and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This "second replenishment sample" was combined for estimation and analysis purposes with the Wave 7 adult and youth respondents from the Wave 4 Cohorts who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts. Dataset 0002 (DS0002) contains the data from the State Design Data. This file contains 7 variables and 82,139 cases. The state identifier in the State Design file reflects the participant's state of residence at the time of selection and recruitment for the PATH Study. Dataset 1011 (DS1011) contains the data from the Wave 1 Adult Questionnaire. This data file contains 2,021 variables and 32,320 cases. Each of the cases represents a single, completed interview. Dataset 1012 (DS1012) contains the data from the Wave 1 Youth and Parent Questionnaire. This file contains 1,431 variables and 13,651 cases. Dataset 1411 (DS1411) contains the Wave 1 State Identifier data for Adults and has 5 variables and 32,320 cases. Dataset 1412 (DS1412) contains the Wave 1 State Identifier data for Youth (and Parents) and has 5 variables and 13,651 cases. The same 5 variables are in each State Identifier dataset, including PERSONID for linking the State Identifier to the questionnaire and biomarker data and 3 variables designating the state (state Federal Information Processing System (FIPS), state abbreviation, and full name of the state). The State Identifier values in these datasets represent participants' state of residence at the time of Wave 1, which is also their state of residence at the time of recruitment. Dataset 1611 (DS1611) contains the Tobacco Universal Product Code (UPC) data from Wave 1. This data file contains 32 variables and 8,601 cases. This file contains UPC values on the packages of tobacco products used or in the possession of adult respondents at the time of Wave 1. The UPC values can be used to identify and validate the specific products used by respon

United States US: Smoking Prevalence: Total: % of Adults: Aged 15+ data was reported at 21.800 % in 2016. This records a decrease from the previous number of 22.300 % for 2015. United States US: Smoking Prevalence: Total: % of Adults: Aged 15+ data is updated yearly, averaging 23.900 % from Dec 2000 (Median) to 2016, with 9 observations. The data reached an all-time high of 31.400 % in 2000 and a record low of 21.800 % in 2016. United States US: Smoking Prevalence: Total: % of Adults: Aged 15+ data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of smoking is the percentage of men and women ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis. It excludes smokeless tobacco use. The rates are age-standardized.; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

To measure changes in America's use of tobacco products as well as to understand public attitudes about smoking.

The Population Assessment of Tobacco and Health (PATH) Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study was launched in 2011 to inform the FDA's tobacco regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). For Wave 1 (baseline), the PATH Study sampled over 150,000 mailing addresses across the United States to create a national sample of people who use or do not use tobacco, yielding interviews with 45,971 adult and youth respondents. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent.At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled PSUs and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort.At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This second replenishment sample was combined for estimation and analysis purposes with Wave 7 adult and youth respondents from the Wave 4 Cohort who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7. This combined set of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts.Biospecimen Collection Each adult respondent, who completed the interview at Wave 1, was asked to provide at least two biospecimens. Providing biospecimens was voluntary and was not a condition of participation. Respondents were asked to report their use of all nicotine-containing products during the 3-day period prior to the time of any biospecimen collection (Nicotine Exposure Questions (NEQs)) to facilitate interpretation of biomarker results. Of the 32,320 respondents who completed the adult interview at Wave 1, 21,801 (67.4 percent) provided a urine specimen and 14,520 (44.9 percent) provided a blood specimen. For the purposes of subsampling adults into the Wave 1 Biomarker Core, adult participants were grouped by tobacco product use at Wave 1 into nine mutually exclusive groups.A sample of 11,522 adults who provided sufficient urine for the planned analyses were selected from the first six tobacco product use groups see section 3.1 of the Biomarker Restricted-Use Files User Guide representing people who never used tobacco, currently use tobacco, and formerly used tobacco (within the last 12 months). This group constitutes the original Wave 1 Biomarker Core. Of the 11,522 adults, 7,159 also provided a blood specimen. All urine and blood specimens provided by the Wave 1 Biomarker Core were sent for laboratory analysis.Subsequent to this selection, an additional stratified probability sample of adults who completed the Wave 1 adult interview and provided a sufficient amount of urine for the planned analyses at Wave 1 (independent of whether th

United States US: Smoking Prevalence: Males: % of Adults data was reported at 24.600 % in 2016. This records a decrease from the previous number of 25.100 % for 2015. United States US: Smoking Prevalence: Males: % of Adults data is updated yearly, averaging 26.800 % from Dec 2000 (Median) to 2016, with 9 observations. The data reached an all-time high of 34.500 % in 2000 and a record low of 24.600 % in 2016. United States US: Smoking Prevalence: Males: % of Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s USA – Table US.World Bank: Health Statistics. Prevalence of smoking, male is the percentage of men ages 15 and over who currently smoke any tobacco product on a daily or non-daily basis. It excludes smokeless tobacco use. The rates are age-standardized.; ; World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).; Weighted average;

The Population Assessment of Tobacco and Health (PATH) Study began originally surveying 45,971 adult and youth respondents. The PATH Study was launched in 2011 to inform Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of people who use or do not use tobacco. 45,971 adults and youth constitute the first (baseline) wave of data collected by this longitudinal cohort study. These 45,971 adults and youth along with 7,207 "shadow youth" (youth ages 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled Primary Sampling Unit (PSU)s and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort.Dataset 0001 (DS0001) contains the data from the Master Linkage file. This file contains 14 variables and 67,276 cases. The file provides a master list of every person's unique identification number and what type of respondent they were for each wave. At Wave 7, a probability sample of 14,863 adults, youth, and shadow youth ages 9 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 7. This sample was recruited from residential addresses not selected for Wave 1 or Wave 4 in the same sampled PSUs and segments using similar within-household sampling procedures. This second replenishment sample was combined for estimation and analysis purposes with Wave 7 adult and youth respondents from the Wave 4 Cohort who were at least age 15 and in the civilian, noninstitutionalized population at the time of Wave 7. This combined set of Wave 7 participants, 46,169 participants in total, forms the Wave 7 Cohort. Please refer to the Public-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1, Wave 4, and Wave 7 Cohorts.Dataset 1001 (DS1001) contains the data from the Wave 1 Adult Questionnaire. This data file contains 1,732 variables and 32,320 cases. Each of the cases represents a single, completed interview. Dataset 1002 (DS1002) contains the data from the Youth and Parent Questionnaire. This file contains 1,228 variables and 13,651 cases.Dataset 2001 (DS2001) contains the data from the Wave 2 Adult Questionnaire. This data file contains 2,197 variables and 28,362 cases. Of these cases, 26,447 also completed a Wave 1 Adult Questionnaire. The other 1,915 cases are "aged-up adults" having previously completed a Wave 1 Youth Questionnaire. Dataset 2002 (DS2002) contains the data from the Wave 2 Youth and Parent Questionnaire. This data file contains 1,389 variables and 12,172 cases. Of these cases, 10,081 also completed a Wave 1 Youth Questionnaire. The other 2,091 cases are "aged-up youth" having previously been sampled as "shadow youth." Dataset 3001 (DS3001) contains the data from the Wave 3 Adult Questionnaire. This data file contains 2,139 variables and 28,148 cases. Of these cases, 26,241 are continuing adults having completed a prior Adult Questionnaire. The other 1,907 cases are "aged-up adults" having previously completed a Youth Questionnaire. Dataset 3002 (DS3002) contains the data from t

The PATH Study was launched in 2011 to inform the Food and Drug Administration's regulatory activities under the Family Smoking Prevention and Tobacco Control Act (TCA). The PATH Study is a collaboration between the National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH), and the Center for Tobacco Products (CTP), Food and Drug Administration (FDA). The study sampled over 150,000 mailing addresses across the United States to create a national sample of tobacco users and non-users. 45,971 adults and youth constitute the first (baseline) wave, Wave 1, of data collected by this longitudinal cohort study. These 45,971 adults and 9 to 11 sampled at Wave 1) make up the 53,178 participants that constitute the Wave 1 Cohort. Respondents are asked to complete an interview at each follow-up wave. Youth who turn 18 by the current wave of data collection are considered "aged-up adults" and are invited to complete the Adult Interview. Additionally, "shadow youth" are considered "aged-up youth" upon turning 12 years old, when they are asked to complete an interview after parental consent. At Wave 4, a probability sample of 14,098 adults, youth, and shadow youth ages 10 to 11 was selected from the civilian, noninstitutionalized population at the time of Wave 4. This sample was recruited from residential addresses not selected for Wave 1 in the same sampled primary sampling units (PSU)s and segments using similar within-household sampling procedures. This "replenishment sample" was combined for estimation and analysis purposes with Wave 4 adult and youth respondents from the Wave 1 Cohort who were in the civilian, noninstitutionalized population at the time of Wave 4. This combined set of Wave 4 participants, 52,731 participants in total, forms the Wave 4 Cohort. Please refer to the Restricted-Use Files User Guide that provides further details about children designated as "shadow youth" and the formation of the Wave 1 and Wave 4 Cohorts. Wave 4.5 was a special data collection for youth only who were aged 12 to 17 at the time of the Wave 4.5 interview. Wave 4.5 was the fourth annual follow-up wave for those who were members of the Wave 1 Cohort. For those who were sampled at Wave 4, Wave 4.5 was the first annual follow-up wave. Wave 5.5, conducted in 2020, was a special data collection for Wave 4 Cohort youth and young adults ages 13 to 19 at the time of the Wave 5.5 interview. Also in 2020, a subsample of Wave 4 Cohort adults ages 20 and older were interviewed via the PATH Study Adult Telephone Survey (PATH-ATS). Dataset 1002 (DS1002) contains the data from the Wave 4.5 Youth and Parent Questionnaire. This file contains 1,617 variables and 13,131 cases. Of these cases, 11,378 are continuing youth having completed a prior Youth Interview. The other 1,753 cases are "aged-up youth" having previously been sampled as "shadow youth" Datasets 1112, 1212, and 1222, (DS1112, DS1212, and DS1222) are data files comprising the weight variables for Wave 4.5. The "all-waves" weight file contains weights for participants in the Wave 1 Cohort who completed a Wave 4.5 Youth Interview and completed interviews (if old enough to do so) or verified their information with the study (if not old enough to be interviewed) in Waves 1, 2, 3, and 4. There are two separate files with "single wave" weights: one for the Wave 1 Cohort and one for the Wave 4 Cohort. The "single-wave" weight file for the Wave 1 Cohort contains weights for youth who completed an interview in Wave 1 and in Wave 4.5, regardless of their participation in the intervening waves. The "single-wave" weight file for the Wave 4 Cohort contains weights for all Wave 4.5 Youth Interview respondents in the Wave 4 Cohort. Dataset 1402 (DS1402) contains the Wave 4.5 State Identifier data for Youth and Parents and has 5 variables and 13,131 cases. The State Identifier dataset includes PERSONID for linking the State Identifier to the questionnaire data and 3 variables designating the state (state Federal Information Processing System (FIPS), state abbreviation, and full name of the state). The State Identifier values in this dataset represent participants' state of residence at the time of Wave 4.5. Dataset 1503 (DS1503) contains data derived from responses to questionnaires in Wave 1, Wave 2, Wave 3, Wave 4, and Wave 4.5 indicating if participants had ever/never used various tobacc

United States US: Prevalence of Current Tobacco Use: % of Adults data was reported at 23.000 % in 2020. This records a decrease from the previous number of 23.400 % for 2019. United States US: Prevalence of Current Tobacco Use: % of Adults data is updated yearly, averaging 25.300 % from Dec 2000 (Median) to 2020, with 7 observations. The data reached an all-time high of 33.800 % in 2000 and a record low of 23.000 % in 2020. United States US: Prevalence of Current Tobacco Use: % of Adults data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s United States – Table US.World Bank.WDI: Social: Health Statistics. The percentage of the population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.;World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/).;Weighted average;This is the Sustainable Development Goal indicator 3.a.1 [https://unstats.un.org/sdgs/metadata/]. Previous indicator name: Smoking prevalence, total (ages 15+) The previous indicator excluded smokeless tobacco use, while the current indicator includes. The indicator name and definition were updated in December, 2020.

Analysis of ‘National Adult Tobacco Survey - United States’ provided by Analyst-2 (analyst-2.ai), based on source dataset retrieved from https://www.kaggle.com/yamqwe/national-adult-tobacco-survey-natse on 28 January 2022.

--- Dataset description provided by original source is as follows ---

About this dataset

2013-2014. The National Adult Tobacco Survey (NATS) was created to assess the prevalence of tobacco use, as well as the factors promoting and impeding tobacco use among adults. NATS also establishes a comprehensive framework for evaluating both the national and state-specific tobacco control programs. NATS was designed as a stratified, national, landline, and cell phone survey of non-institutionalized adults aged 18 years and older residing in the 50 states or D.C. It was developed to yield data representative and comparable at both national and state levels. The sample design also aims to provide national estimates for subgroups defined by gender, age, and race/ethnicity.

Source: https://catalog.data.gov/dataset/national-adult-tobacco-survey-nats
Last updated at https://catalog.data.gov/organization/hhs-gov : 2021-04-25

This dataset was created by US Open Data Portal, data.gov and contains around 100 samples along with Locationdesc, Age, technical information and other features such as: - Topictypeid - Datasource - and more.

How to use this dataset

• Analyze Stratificationid4 in relation to Race
• Study the influence of Stratificationid1 on Low Confidence Limit
• More datasets

Acknowledgements

If you use this dataset in your research, please credit US Open Data Portal, data.gov

--- Original source retains full ownership of the source dataset ---

Percentages are weighted to population characteristics. Data are not available if it did not meet BRFSS stability requirements.For more information on these requirements, as well as risk factors and calculated variables, see the Technical Documents and Survey Data for a specific year - http://www.cdc.gov/brfss/annual_data/annual_data.htm.Recommended citation: Centers for Disease Control and Prevention (CDC). Behavioral Risk Factor Surveillance System. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, [appropriate year].

United States CPI U: AW: GS: Tobacco & Smoking Products (TS) data was reported at 0.693 % in 2017. This records an increase from the previous number of 0.665 % for 2016. United States CPI U: AW: GS: Tobacco & Smoking Products (TS) data is updated yearly, averaging 0.818 % from Dec 1997 (Median) to 2017, with 21 observations. The data reached an all-time high of 1.402 % in 2001 and a record low of 0.665 % in 2016. United States CPI U: AW: GS: Tobacco & Smoking Products (TS) data remains active status in CEIC and is reported by Bureau of Labor Statistics. The data is categorized under Global Database’s United States – Table US.I011: Consumer Price Index: Urban: Weights (Annual).

This statistic shows the usage of tobacco products other than cigarettes in the United States from 2011 to 2020 and a forecast thereof until 2024. The data has been calculated by Statista based on the U.S. Census data and Simmons National Consumer Survey (NHCS). According to this statistic, 12.46 million Americans used tobacco products other than cigarettes in 2020. This figure is projected to decrease to 11.78 million in 2024.

Smoking rates for each Census Tract in Allegheny County were produced for the study “Developing small-area predictions for smoking and obesity prevalence in the United States.” The data is not explicitly based on population surveys or data collection conducted in Allegheny County, but rather estimated using statistical modeling techniques. In this technique, researchers applied the smoking rate of a demographically similar Census Tract to one in Allegheny County to compute a smoking rate.

Support for Health Equity datasets and tools provided by Amazon Web Services (AWS) through their Health Equity Initiative.

Graph and download economic data for Tobacco Consumption, Large Cigars for United States (M0186DUSM397NNBR) from Jan 1915 to Dec 1951 about tobacco, consumption, and USA.

1995-2024. Centers for Disease Control and Prevention (CDC). State Tobacco Activities Tracking and Evaluation (STATE) System. E-Cigarette Legislation—Smokefree Indoor Air. The STATE System houses current and historical state-level legislative data on tobacco use prevention and control policies. Data are reported on a quarterly basis. Data include information related to state legislation on smokefree indoor air in areas such as: Bars, Commercial Day Care Centers, Government Multi-Unit Housing, Government Worksites, Home-Based Day Care Centers, Hotels and Motels, Personal Vehicles, Private Multi-Unit Housing, Private Worksites, Restaurants, Bingo Halls, Casinos, Enclosed Arenas, Grocery Stores, Hospitals, Hospital Campuses, Malls, Mental Health Outpatient and Residential Facilities, Prisons, Public Transportation, Racetrack Casinos, Substance Abuse Outpatient and Residential Facilities.

Data are provided in this collection on labor force activity for the week prior to the survey. Comprehensive data are available on the employment status, occupation, and industry of persons 15 years old and older. Also shown are personal characteristics such as age, sex, race, marital status, veteran status, household relationship, educational background, and Hispanic origin. In addition to providing these core data, this survey also contains a special supplement on tobacco use for all persons surveyed. This supplement includes information on cigarette smoking and use of other tobacco products such as pipes, cigars, chewing tobacco, and snuff. Respondents answered a set of detailed questions tailored to their smoking status, such as how many cigarettes they smoked per day, and whether respondents had smoked everyday for the past six months. Additionally, respondents were asked whether the medical community had advised them to quit smoking or if they were planning to quit in the near future. Detailed questions on smoking policies in the respondents' workplace and smoking at home were also asked.

This is a source dataset for a Let's Get Healthy California indicator at https://letsgethealthy.ca.gov/. Adult smoking prevalence in California, males and females aged 18+, starting in 2012. Caution must be used when comparing the percentages of smokers over time as the definition of ‘current smoker’ was broadened in 1996, and the survey methods were changed in 2012. Current cigarette smoking is defined as having smoked at least 100 cigarettes in lifetime and now smoking every day or some days. Due to the methodology change in 2012, the Centers for Disease Control and Prevention (CDC) recommend not conducting analyses where estimates from 1984 – 2011 are compared with analyses using the new methodology, beginning in 2012. This includes analyses examining trends and changes over time. (For more information, please see the narrative description.) The California Behavioral Risk Factor Surveillance System (BRFSS) is an on-going telephone survey of randomly selected adults, which collects information on a wide variety of health-related behaviors and preventive health practices related to the leading causes of death and disability such as cardiovascular disease, cancer, diabetes and injuries. Data are collected monthly from a random sample of the California population aged 18 years and older. The BRFSS is conducted by Public Health Survey Research Program of California State University, Sacramento under contract from CDPH. The survey has been conducted since 1984 by the California Department of Public Health in collaboration with the Centers for Disease Control and Prevention (CDC). In 2012, the survey methodology of the California BRFSS changed significantly so that the survey would be more representative of the general population. Several changes were implemented: 1) the survey became dual-frame, with both cell and landline random-digit dial components, 2) residents of college housing were eligible to complete the BRFSS, and 3) raking or iterative proportional fitting was used to calculate the survey weights. Due to these changes, estimates from 1984 – 2011 are not comparable to estimates from 2012 and beyond. Center for Disease Control and Policy (CDC) and recommend not conducting analyses where estimates from 1984 – 2011 are compared with analyses using the new methodology, beginning in 2012. This includes analyses examining trends and changes over time.Current cigarette smoking was defined as having smoked at least 100 cigarettes in lifetime and now smoking every day or some days. Prior to 1996, the definition of current cigarettes smoking was having smoked at least 100 cigarettes in lifetime and smoking now.